HQY
HealthEquity, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$96.07
−2.74%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.4B | 1.3B | 1.2B | 999.6M | 861.7M |
| Cost of Revenue | 337.6M | 400.3M | 507.2M | 469.7M | 466.2M |
| Gross Profit | 1.0B | 913.1M | 692.6M | 529.9M | 395.5M |
| Operating Expenses | |||||
| R&D Expense | 278.0M | 262.5M | 239.5M | 218.8M | 193.4M |
| SG&A Expense | 342.8M | 328.1M | 223.0M | 182.9M | 164.5M |
| General & Admin Expense | 243.4M | 232.9M | 132.3M | 103.7M | 95.6M |
| Selling & Marketing Expense | 99.4M | 95.2M | 90.7M | 79.3M | 68.8M |
| Other Expenses | 54.9M | — | — | — | — |
| Total Operating Expenses | 675.6M | 590.7M | 462.5M | 401.7M | 357.9M |
| Cost and Expenses | 1.0B | 991.0M | 969.7M | 871.5M | 824.1M |
| Operating Income (EBIT) | 348.9M | 322.5M | 230.1M | 128.1M | 37.7M |
| Non-Operating | |||||
| Interest Income | 7.9M | 12.1M | 13.9M | 12.1M | 1.8M |
| Interest Expense | 52.5M | 57.1M | 60.6M | 55.5M | 48.4M |
| Net Interest Income | (44.6M) | (45.0M) | (46.7M) | (43.3M) | (46.7M) |
| Other Non-Op Income/Expense | (40.2M) | (45.0M) | (114.0M) | (53.1M) | (75.7M) |
| Non-Operating Income (excl Interest) | 11.4M | (12.1M) | 55.0M | (1.2M) | 27.3M |
| EBT (Pre-Tax Income) | 308.7M | 277.4M | 116.0M | 75.0M | (38.1M) |
| Income Tax Expense | 72.2M | 62.2M | 19.3M | 19.3M | (12.0M) |
| Bottom Line | |||||
| Net Income | 236.5M | 215.2M | 96.7M | 55.7M | (26.1M) |
| Earnings from Cont. Ops | 236.5M | 215.2M | 96.7M | 55.7M | (26.1M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 236.5M | 215.2M | 96.7M | 55.7M | (26.1M) |
| Per Share | |||||
| Basic EPS | $2.80 | $2.50 | $1.11 | $0.65 | ($0.31) |
| Diluted EPS | $2.77 | $2.46 | $1.09 | $0.64 | ($0.31) |
| Revenue Per Share | $16.34 | $15.25 | $13.81 | $11.68 | $10.21 |
| Shares | |||||
| Basic Shares Outstanding | 83.4M | 86.1M | 86.9M | 85.6M | 84.4M |
| Diluted Shares Outstanding | 84.0M | 87.5M | 88.8M | 87.0M | 84.4M |
| Profitability Metrics | |||||
| EBITDA | 469.5M | 489.2M | 337.5M | 282.4M | 171.5M |
| D&A | 132.0M | 154.7M | 162.5M | 153.1M | 161.2M |
| EBIT | 337.4M | 334.6M | 175.1M | 129.3M | 10.3M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jul 1, 2026